Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1

Hsa-miRNA-134 (miR-134) has recently been discovered to have anticancer efficacy in different organs. However, the role of miR-134 on non-small cell lung cancer (NSCLC) is still ambiguous. In this study, we investigated the role of miR-134 on the development of NSCLC. The results indicated that miR-...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Cheng-Cao, Li, Shu-Jun, Li, De-Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094975/
https://www.ncbi.nlm.nih.gov/pubmed/27166267
http://dx.doi.org/10.18632/oncotarget.8482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094975/
https://www.ncbi.nlm.nih.gov/pubmed/27166267
http://dx.doi.org/10.18632/oncotarget.8482

Ejemplares similares